Skip to main content

Table 4 Multivariate analysis of overall survival of AML patients associated with VIM expression Z-score ≥ 1 in older patients (age ≥ 60; n = 80)

From: Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia

Variables Hazard ratio 95% CI p value
Age 1.02 0.97 1.06 0.451
Cytogenetic risk
 Intermediate 0.90 0.35 2.32 0.828
  Poor 3.60 1.18 11.0 0.024
Transplant status 0.274 0.12 0.62 0.002
 DNMT3A 1.77 0.94 3.32 0.077
 RUNX1 1.67 0.72 3.86 0.230
 TP53 1.31 0.57 3.01 0.517
 VIM 1.99 1.04 3.81 0.038